STOCKBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)Updated 2026-07-26
Here’s whether BiomX Inc. (PHGE) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bearish.
🔴
Bearish
Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-15.01% over 10 days); RSI 10 — oversold; weak 1-year return of -97.7%; 3-month momentum negative (-83.0%). Currently 98.6% off its 52-week high. Score: -7/7.
PHGE is trading below its 200-day MA ($3.77) — a key warning sign the longer-term trend is under pressure. An RSI of 10.3 has dropped into oversold territory, which has historically preceded short-term bounces. The 1-year return of -97.7% compares to +16.5% for SPY (trailed the market by 114.2%). The current 98.6% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.
$10,000 invested 1 year ago→ $227 today
vs. S&P 500 (SPY) — same period trailed market by 114.2%